Role of Cav1.2 in cisplatin induced apoptosis of cochlear spiral ganglion neurons in C57BL/6J mice

doi:10.12047/j.cjap.6272.2022.066

Abstract

Abstract: Objective: To investigate the role of Cav1.2 and its possible mechanism in the apoptosis of cochlear spiral ganglion neurons(SGNs) induced by cisplatin (CDDP) in C57BL/6J mice. Methods: Animal experiment: 8-week-old male C57BL/6J mice were randomly divided into the following two groups (10 mice/group) : normal saline group (Control group) and Cisplatin group (Cisplatin group). The Control group received daily intraperitoneal injections of normal saline, Cisplatin group was injected with cisplatin intraperitoneally at a dose of 3 mg/kg at the first 4 days of each cycle, and normal saline was injected daily at the last 10 days,repeat for 3 cycles. After administration, auditory threshold was detected by auditory brainstem response (ABR). Blood samples were collected from inner canthus of mice, and cochlea was cut off from neck. SOD and MDA kits were used to detect SOD activity and MDA content in serum and cochlea tissues. The expressions of apoptosis proteins in cochlear tissues were detected by Western blot. Morphological changes of spiral ganglion in mouse cochlea were observed by hematoxylin-eosin (HE) staining. TUNEL staining was used to observe the apoptosis of SGNs in cochlea of mice. The distribution and expression of Cav1.2 in SGNs of cochlea were observed by immunofluorescence. Cell experiment: Primary cultured SGNs were randomly divided into: control group (Control), solvent group (DMSO), Cav1.2 blocker group (N), cisplatin group, cisplatin and Cav1.2 blocker co-incubation group (Cisplatin+N). 5 μmol/L cisplatin was selected to treat SGNs based on the results of CCK8. Western blot was used to detect the protein expressions of Cav1.2.and apoptotic proteins. Hoechst33342 staining was used to observe the apoptosis of each group. Flow cytometry was used to detect the apoptosis rate of each group. Mitochondrial superoxide indicator (MitoSOX^TM-Red) was used to detect the ROS release of mitochondria. Results: Animal experiments: Compared to the Control group, the hearing threshold was increased in Cisplatin group (P<0.01), the content of MDA in serum and cochlea tissues, apoptosis protein Cleaved caspase-3, Bax protein level, TUNEL positive rate, Cav1.2 protein expression level were increased significantly (P<0.05, P<0.01); the activity of SOD in serum and cochlear tissue, anti-apoptotic protein bcl-2 protein level and SGCs density in cochlear tissue were decreased significantly (P<0.05, P<0.01). Cell tests: Compared with the Control group, the expression of Cav1.2, apoptosis rate, Cleaved caspase-3, Bax protein level, intracellular calcium ion concentration, and ROS release were increased significantly only in Cisplatin group (P<0.05, P<0.01). The levels of bcl-2 protein and mitochondrial membrane potential were decreased significantly (P<0.01). Cav1.2 blockers could partially reverse the above changes (P<0.05). Conclusion: Cisplatin may increase intracellular Ca²⁺ concentration through up-regulation of Cav1.2, and then damage mitochondria, causing oxidative stress injury of SGNs and inducing neuronal apoptosis.

Key words: Cisplatin, Cav1.2, mice, cell culture, cochlear spiral ganglion neurons, apoptosis

CLC Number:

R339.16

MA Jing-wen, WANG Yan-ping, WANG Min, HUANG Tian-lan, SHI Tian-feng, YU Miao, SI Jun-qiang, LI Li. Role of Cav1.2 in cisplatin induced apoptosis of cochlear spiral ganglion neurons in C57BL/6J mice[J]. CJAP, 2022, 38(4): 348-355.

References

[1] Anniko M, Sobin A.Cisplatin: evaluation of its ototoxic potential[J]. Am J Otolaryngol, 1986, 7(4): 276-293.
[2] Frisina RD, Wheeler HE, Fossa SD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer[J]. J Clin Oncol, 2016, 34(23): 2712-2720.
[3] Rybak LP, Whitworth CA, Mukherjea D, et al. Mechanisms of cisplatin-induced ototoxicity and prevention[J]. Hear Res, 2007, 226(1-2): 157-167.
[4] Mukherjea D, Rybak LP.Pharmacogenomics of cisplatin-induced ototoxicity[J]. Pharmacogenomics, 2011, 12(7): 1039-1050.
[5] 邓志宏, 邱建华, 王锦玲, 等. NT3 基因转染对小鼠耳蜗螺旋神经节细胞生长的影响[J]. 中华神经外科疾病研究杂志, 2004, 3(3): 249-251.
[6] Lv P, Kim HJ, Lee JH, et al. Genetic, cellular, and functional evidence for Ca2+ inflow through Cav1. 2 and Cav1. 3 channels in murine spiral ganglion neurons[J]. J Neurosci, 2014, 34(21): 7383-7393.
[7] 丁大连, 亓卫东, 张梅, 等. 顺铂及其耳毒性[J]. 中华耳科学杂志, 2008, 6(2): 125-125.
[8] 陈龙, 杨玉琪, 冯子奕, 等. 雌激素对老年 C57BL/6J 小鼠耳蜗螺旋神经节细胞凋亡的影响[J]. 中国应用生理学杂志, 2020, 36(6): 529-533.
[9] 王悦璇, 刘秀均. 顺铂的作用靶点及耐药机制的研究进展[J]. 中国医药生物技术, 2020, 15(3): 316-319.
[10] 潘虹, 施真, 杨泰国, 等. 枸杞多糖对糖尿病大鼠视网膜神经元的保护作用及其机制[J]. 中国应用生理学杂志, 2019, 35(1): 55-59.
[11] Arikkath J, Campbell KP.Auxiliary subunits: essential components of the voltage-gated calcium channel complex[J]. Curr Opin Neurobiol, 2003, 13(3): 298-307.
[12] Moreno C, Hermosilla T, Hardy P, et al. Cav1.2 activity and downstream signaling pathways in the hippocampus of an animal model of depression[J]. Cells, 2020, 9(12): 2609.
[13] Liao Q, Zhang R, Wang X, et al. Effect of fluoride exposure on mRNA expression of cav1. 2 and calcium signal pathway apoptosis regulators in PC12 cells[J]. Environ Toxicol Pharmacol, 2017, 54: 74-79.
[14] Yang L, Katchman A, Weinberg RL, et al. The PDZ motif of the α1C subunit is not required for surface trafficking and adrenergic modulation of CaV1. 2 channel in the heart[J]. J Biol Chem, 2015, 290(4): 2166-2174.
[15] Cao X, Chen Y.Mitochondria and calcium signaling in embryonic development[J]. Semin cell Dev Biol, 2009, 20(3): 337-345.
[16] Williams G, Boyman L, Chikando AC, et al. Mitochondrial calcium uptake[J]. P Natl Acad Sci USA, 2013, 110(26): 10479-10486.
[17] Ma L, Wang H, Wang C, et al. Failure of elevating calcium induces oxidative stress tolerance and imparts cisplatin resistance in ovarian cancer cells[J]. Aging Dis, 2016, 7(3): 254-266.